Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®-Reference-Cited by-同舟云学术

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®

Published:2004-06 Issue:17-18 Volume:22 Page:2103-2105
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kitchener Scott

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference10 articles.

1. CDC. Notice to readers: fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996–2001, MMWR 2001;50:643–5.

2. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases;Martin;Lancet,2001

3. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases;Vasconcelos;Lancet,2001

4. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine;Chan;Lancet,2001

5. Effects of yellow fever vaccination;Adhiyaman;Lancet,2001

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying and reducing risks of neurological complications associated with vaccination;Nature Reviews Neurology;2024-08-07

2. Recovery of yellow fever virus whole genome from an individual with severe vaccine-associated viscerotropic disease;The Lancet Microbe;2024-05

3. Recent Advances in Arboviral Vaccines: Emerging Platforms and Promising Innovations;Biologics;2023-12-22

4. Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD;Vaccines;2023-02-15

5. Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates;Vaccine;2023-01